在一个半的左心室辅助器件患者中使用HeartMate III自主助手:一个案例报告
Manuel Iafrate1, Lorraine Aviolat2, Filipa Monis Vieira Marques2
1From the Department of Cardiac Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
概括
一个新的自主工具帮助半患者管理左心室辅助器件 (LVAD) 电源,改善他们的独立性和心脏手术后的生活质量. 这个设备简化了动力障碍者电池更换.
科学领域:
- 心血管医学 心血管医学
- 生物医学工程 生物医学工程
- 康复科学 康复科学 康复科学
背景情况:
- 最终性心力衰竭需要先进的治疗方法,如心脏移植或机械循环支持.
- 供体器官的有限可用性强调了机械支持系统的关键作用.
- 离心流的左心室辅助装置 (LVAD) 与轴流系统相比,为患者提供了更好的结果,减少了不良事件.
研究的目的:
- 开发一种自主工具,以帮助半患者管理LVAD电源.
- 为了提高LVADs的运动障碍患者的自主性和生活质量.
- 为应对LVAD接收者中风后电源管理方面的挑战.
主要方法:
- 一名44岁的男性患有缺血性心脏病和低射出分数,接受了双重旁路和LVAD植入.
- 手术后,患者发生了中风,导致左侧运动障碍.
- 为LVAD电源管理设计并实施了一种具有木支底座和防滑表面的自主工具.
主要成果:
- 开发的工具显著改善了患者的自主权和生活质量.
- 现实世界的证据表明,电池更换的时间缩短,与更换电池相关的警报减少.
- 该设备在家庭环境中是有效的,并且可以适应各种移动水平.
结论:
- 这种自主工具有效地增强了 LVAD 的半性患者的自我护理和独立性.
- 该设备显着有望改善需要机械循环支持的运动障碍患者的生活.
- 需要进一步的研究来评估这种辅助技术的长期好处和挑战.
相关概念视频
Cardiomyopathy V: Interprofessional Care
1
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
1
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiopulmonary Resuscitation III: AED Use
1
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1
Heart Failure VI: Adjunct Therapies
1
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1
Heart Failure V: Medical Management
1
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
1


